Sheen-Chen S, Chen W, Eng H, Sheen C, Chou F, Cheng Y, Lee T
Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, College of Medicine, Chang Gung University, Taiwan.
Am J Infect Control. 2000 Aug;28(4):298-301. doi: 10.1067/mic.2000.107071.
Hepatolithiasis is prevalent in southeast Asia and presents a difficult management problem. Acute repeated episodes of cholangitis are frequently manifested in patients with hepatolithiasis. Without proper treatment, such infection can lead to liver abscess, secondary biliary cirrhosis, portal hypertension, and death from sepsis or hepatic failure. In addition to clearance of the stones and relief of bile stasis either by surgery or by interventional radiologic manipulation, effective antimicrobial therapy also plays a crucial role in the treatment of patients with hepatolithiasis. The aim of this study is to clarify the bacteriology in hepatolithiasis and to provide the information for an appropriate antimicrobial choice.
From July 1993 to June 1996, 150 patients with hepatolithiasis underwent surgical intervention. Bile specimens were routinely obtained by syringe aspiration from common bile duct. The syringe was immediately capped, and the bile was subsequently cultured for both aerobes and anaerobes.
Bacteria were present in the bile of all patients. The bacteria most frequently found were gram-negative bacteria such as Klebsiella sp, Escherichia coli, and Pseudomonas sp, and the gram-positive Enterococcus sp. Bacteroides sp were the most frequently found anaerobes.
This study demonstrated the close relationship between acute cholangitis in hepatolithiasis and enteric bacteria and also displayed the detailed antibiotic sensitivity results. Armed with this fruitful information, we believe the antibiotic treatment for acute cholangitis in hepatolithiasis should first aim at enteric bacteria and be adjusted later according to the results of bacteriologic cultures and clinical situation to achieve an effective microbial control.
肝内胆管结石在东南亚地区较为常见,其治疗颇具难度。肝内胆管结石患者常反复出现急性胆管炎发作。若未得到恰当治疗,此类感染可导致肝脓肿、继发性胆汁性肝硬化、门静脉高压,以及因败血症或肝衰竭而死亡。除通过手术或介入放射学操作清除结石并缓解胆汁淤积外,有效的抗菌治疗在肝内胆管结石患者的治疗中也起着关键作用。本研究旨在明确肝内胆管结石的细菌学情况,并为合理选择抗菌药物提供依据。
1993年7月至1996年6月,150例肝内胆管结石患者接受了手术治疗。通过注射器从胆总管常规抽取胆汁标本。注射器立即加盖密封,随后对胆汁进行需氧菌和厌氧菌培养。
所有患者的胆汁中均发现有细菌。最常发现的细菌为革兰氏阴性菌,如克雷伯菌属、大肠埃希菌和假单胞菌属,以及革兰氏阳性菌肠球菌属。拟杆菌属是最常发现的厌氧菌。
本研究证实了肝内胆管结石急性胆管炎与肠道细菌之间的密切关系,同时也展示了详细的抗生素敏感性结果。基于这些丰富的信息,我们认为肝内胆管结石急性胆管炎的抗生素治疗应首先针对肠道细菌,并随后根据细菌学培养结果和临床情况进行调整,以实现有效的微生物控制。